Company
Last deal
$4.6M
Amount
Series A
Stage
06.02.2014
Date
2
all rounds
$4.6M
Total amount
General
About Company
TNG Pharmaceuticals is developing FlyVax, a veterinary vaccine that inhibits horn flies.
Industry
Sector :
Subsector :
founded date
01.01.2011
Operating Status
Closed
Number of employees
Company Type
For Profit
Last funding type
Series A
IPO status
Private